Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
about
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaHuman recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesRecombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaEmergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patientsRecombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaRecombinant factor VIIa as haemostatic therapy in advanced liver diseaseChanging Concepts of Cirrhotic Coagulopathy.Medical and endoscopic management of gastric varices.Procoagulant therapeutics in liver disease: a critique and clinical rationale.[Therapy with blood products].Venous thromboembolism in cirrhosis.'The TIPSing Point'.Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis.Management of acute variceal bleeding.Treatment of portal hypertensionClinical pharmacology of portal hypertension.Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysisVariceal bleeding: consensus meeting report from the Brazilian Society of Hepatology.Acute esophageal variceal bleeding: Current strategies and new perspectivesPrevention and management of gastroesophageal varices in cirrhosis.Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.Update of endoscopy in liver disease: more than just treating varices.The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage.Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding.Improving survival in decompensated cirrhosisManagement by the intensivist of gastrointestinal bleeding in adults and children.The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework.Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Management of varices in cirrhosis.Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension.Blood component support in acquired coagulopathic conditions: is there a method to the madness?Liver disease, coagulopathies and transfusion therapyOff-label use of recombinant factor VIIa in two tertiary hospitals in Queensland.Management of varices in patients with cirrhosis.The coagulation system in patients with end-stage liver disease.Managing complications in cirrhotic patientsGastrointestinal endoscopy in the cirrhotic patient.
P2860
Q24201292-FF19BD2D-58F7-4E2C-9E96-FB9E3572532DQ24201303-EAA249F4-D98C-4256-BC73-7273BE8CD99BQ24236583-76C3610F-3449-4060-BC59-DAF31C998687Q24236772-179C927D-2EC9-409A-9262-15FB20F070ECQ24245204-C0664F5A-40FE-44AC-AD53-4C5573E07551Q26822857-D29882F1-193C-4D53-8071-84550F3F010AQ30275544-59DFECB0-DEA0-4500-B72B-EE50FA087383Q30425322-F0E72E16-3328-455C-B5EB-A1ED7C23289BQ30458618-047CF9D2-4D61-4882-A6DB-0FA136D914F1Q33429614-6E91AB93-65E7-4639-8D69-19B3374A1029Q33724083-B453AB76-F577-4058-BA41-4A36A296AA2FQ33754092-22186CBE-9D68-4323-A074-B24997615AB6Q33756657-7AC0A795-17DE-460E-8E40-00E12EB9C553Q33937329-F5AAEB1B-8225-485E-ABFE-0995D3ED3BE9Q34036903-3EEA28D7-65F1-4354-9BD1-566889A72103Q34265176-4D59C563-D540-439D-B15F-748E249B6AA6Q34399357-4D84F675-D9F0-4EF3-9F36-C856F7B3B7FCQ34472516-8C41A163-5D03-4897-ADDD-9F6FC92D03BEQ34622605-5CC7A456-D303-444B-864D-803E4199EFA0Q34625821-38B61AAD-96E7-4AED-87F0-ABABDABD6501Q34638216-AD8138E6-1C98-4D56-B156-02D50EDB96EEQ34654443-FC34A1A6-0426-42E5-9BD8-D6153BEA3F98Q34786006-5580DE82-8426-4760-991D-D22C6C73D7DBQ35738416-1719B161-3C8C-45F5-BEFB-028DD5432E5EQ35973813-F69EEE96-7CCA-434A-AB14-B081DA355B2DQ35998366-D8BF0A5D-B7D2-418F-A631-011DC03E1A95Q36090423-98E089DF-C358-4C79-A4A2-560754A15588Q36478606-E7544B32-152A-4922-8BCB-1C1CCFA27625Q36537350-83ACF9F4-37D2-4BE8-99E0-98CF51F2E50CQ37019451-500C74AF-6AAF-4616-B1AC-672C37F33E29Q37489472-FC861D65-4464-4902-941F-2E995F71AE0EQ37832507-30CB1AC2-1280-4753-AF45-E5DEAB86786DQ37992682-3FFB2CEC-3302-45A5-9312-AC1AC852F155Q37999723-BDB96BF6-57C6-426D-AEC1-4B070228BCAEQ38051476-2BAD49C0-54A7-4EB5-997E-BECB31710B4CQ38058551-4121CDC8-89EF-424B-BB6A-8D75D67E75FCQ38094881-6C6AB1BC-C6D9-403A-B75D-F4815190C048Q38295874-DF901105-5339-4D53-9590-8B44A354785FQ38344890-E1F30DC0-149F-4F24-A708-E25A37F41084Q38476069-62BC0FE7-734B-4E57-B48A-1D9F8DB133C9
P2860
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Recombinant factor VIIa for va ...... randomized, controlled trial.
@en
Recombinant factor VIIa for va ...... randomized, controlled trial.
@nl
type
label
Recombinant factor VIIa for va ...... randomized, controlled trial.
@en
Recombinant factor VIIa for va ...... randomized, controlled trial.
@nl
prefLabel
Recombinant factor VIIa for va ...... randomized, controlled trial.
@en
Recombinant factor VIIa for va ...... randomized, controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
Recombinant factor VIIa for va ...... randomized, controlled trial.
@en
P2093
Agustín Albillos
Didier Lebrec
Dominique Thabut
Flemming Bendtsen
Gennaro D'Amico
International Study Group on rFVIIa in UGI Hemorrhage
Jaime Bosch
Julien Massard
Julius Spicak
Nicolas Carbonell
P2860
P304
P356
10.1002/HEP.22216
P407
P577
2008-05-01T00:00:00Z